13 studies found for:    12324553 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
Condition: Chronic Hepatitis C
Interventions: Drug: Peg-IFN + WB RBV for 16 weeks;   Drug: Peg-IFN + LD RBV for 16 weeks;   Drug: Peg-IFN + WB RBV for 24 weeks;   Drug: Peg-IFN + WB RBV for 48 weeks;   Drug: Peg-IFN + LD RBV for 24 weeks
2 Unknown  12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.
Condition: Hepatitis C
Intervention: Drug: UT-231B
3 Completed Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9
Conditions: Chronic Hepatitis C;   Asian Americans;   Novel Genotypes;   Treatment
Intervention: Drug: Pegylated interferon and ribavirin
4 Completed
Has Results
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients
Condition: Hepatitis C, Chronic
Intervention: Drug: Pegylated interferon alfa-2a plus ribavirin
5 Unknown  4-Methylumbelliferone as a Treatment for Chronic HBV/HCV
Conditions: Chronic Hepatitis C;   Chronic Hepatitis B
Intervention: Drug: 4-Methylumbelliferone (Heparvit®)
6 Completed Trial of Peg-Interferon Plus Epoetin-Alfa for Treatment of Chronic Hepatitis C Virus Infection
Condition: Hepatitis C
Interventions: Drug: Peginterferon-alpha-2b (PEG-Intron);   Drug: Ribavirin;   Drug: Epoetin-alpha (Procrit)
7 Unknown  Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa and ribavirin
8 Unknown  Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Hepatocellular Carcinoma
Intervention: Drug: peginterferon alpha-2a and ribavirin
9 Completed A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients
Conditions: Chronic Hepatitis C;   Genotype
Interventions: Drug: pegylated interferon alpha 2a and ribavirin;   Drug: Pegylated interferon alfa-2a and ribavirin
10 Completed Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C
Conditions: Chronic Hepatitis C;   Obesity
Intervention:
11 Completed Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment
Condition: Chronic Hepatitis B
Intervention: Drug: Pegylated Interferon-alfa-2a
12 Unknown  Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Neoplasms
Intervention: Drug: pegylated interferon alpha 2a and plus ribavirin
13 Completed
Has Results
Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation
Condition: Hepatitis C
Intervention: Drug: LADR Treatment

Indicates status has not been verified in more than two years